There is a general consensus that the pathology of atherosclerotic plaque formation includes a strong inflammatory component and that selective amelioration of this inflammation could be of therapeutic benefit.^[@R1]^ One of the immune cell subsets implicated in atherosclerosis disease progression are B lymphocytes, which as antibody-secreting cells form the humoral arm of immunity. B cells have been shown to have ambivalent functions in atherosclerotic plaque formation. Splenectomy^[@R2],[@R3]^ or genetic ablation of B cells^[@R4]^ resulted in an overall increase in atherosclerosis in susceptible animal models, whereas acute B-cell depletion via anti-CD20 therapy indicated possible proatherogenic functions.^[@R5],[@R6]^ However, a major humoral function of B cells is the secretion of the so-called natural antibodies that have been proposed to protect against atherosclerosis plaque formation.^[@R7]^ Natural antibodies are generally germline encoded and of the IgM isotype and are thought to be predominately produced by the B-1 type of mature B cells. Mice unable to secrete IgM are more prone to diet-induced atherosclerosis.^[@R8]^ In addition, transfer of B-1 cells that cannot secrete IgM fails to protect against the increase in atherosclerosis in *Apoe*^−/−^ mice that is observed after splenectomy, whereas transfer of wild-type B-1 cells fully restored plasma IgM levels and prevented accelerated lesion formation in these mice.^[@R9]^

Many antigens have been implicated in the process of atherosclerotic lesion formation. Prominent among these is the modification of low-density lipoprotein (LDL) into oxidized low-density lipoprotein (OxLDL).^[@R10],[@R11]^ This modification unmasks the phosphocholine epitope of oxidized phospholipids that is subsequently recognized by the natural antibody identified by the T15-idiotype (T15-id).^[@R12]^ The recognition of OxLDL by T15-id antibodies is thought to mediate protection from atherosclerosis because T15-id IgM antibodies have been shown to limit proinflammatory cytokine secretion by oxidized phospholipids in macrophages, block OxLDL-induced foam cell formation, and promote apoptotic cell clearance.^[@R7],[@R12],[@R13]^

The T15-id was originally discovered as a phosphocholine binding antibody of the IgA subtype from hybridomas obtained after pristane injection.^[@R14]--[@R16]^ The production of the T15-id is thought to be absolutely dependent on a successful V(D)J recombination event between the *V*~*H*~*S107.1.42* (also known as *V1*^[@R17]^), *D*~*H*~*FL16.1* and the *J*~*H*~*1* gene segments.^[@R18],[@R19]^ The immune reaction to phosphocholine in a hapten form is characterized by an early response dominated by T15-id B cell clones. The secondary immune response against phosphocholine differs as the humoral response consists of antibodies that have incorporated *V*~*H*~*S107.1.42* immunoglobulin heavy chains in their rearrangement but are T15-id negative or alternatively uses other *V*~*H*~ genes in a productive V(D)J rearrangement but nevertheless bind phosphocholine.^[@R20],[@R21]^

A well-characterized protective physiological role of T15-id antibodies is the recognition of phosphocholine present in the capsular polysaccharide of *Streptococcus pneumoniae*.^[@R22]^ The T15-id is produced in both germfree and conventional mice from ≈1 week after birth, thereby providing protection against *S pneumoniae* infection as a part of the natural immunoglobulin repertoire.^[@R23]^ Nonimmunized mice deficient for the *V*~*H*~*S107.1.42* gene are highly susceptible to death after *S. pneumonia* infection.^[@R24]^ This is thought to be because of the lack of T15-id antibodies induced in the early immune response that would normally prevent binding of *S pneumoniae* to the platelet-activating factor receptor and subsequent transport across host cell membranes. Immunization of *Ldlr*^−/−^ mice with heat killed *S pneumoniae* increases the titers of T15-id IgM antibodies that bind OxLDL and decreases the extent of atherosclerosis.^[@R22]^ Moreover, infusion of T15-id IgM antibodies reduces plaque formation within grafted veins of Apoe^−/−^ mice, whereas this was not sufficient to affect the extent of native atherosclerosis in the aortic origin.^[@R25]^ In addition, infusion of T15-Id IgM had no effect on accelerated atherosclerosis in a carotid cuff model in *Apoe*^−/−^ mice fed an atherogenic diet.^[@R26]^ However, the duration of the T15-id IgM intervention or the levels achieved by the infusion strategy may not have been sufficient to mediate a protective effect in these studies.

In addition to the T15-id encoding *V*~*H*~*S107.1.42* gene segment, many other V~H~ genes can be incorporated into antiphosphocholine-binding specificities.^[@R27]^ Noticeably, mice that are deficient for *D*~*H*~*FL16.1* lose T15-id IgM production and have increased susceptibility to *S pneumoniae* infection, yet have normal levels of serum anti-OxLDL antibodies.^[@R28]^ Therefore, we wished to determine whether the loss of the *V*~*H*~*S107.1.42* gene is similarly critical against the development of atherosclerosis as it is for the protection against lethal *S pneumoniae* infection. We present evidence that the atheroprotective effects of IgM do not depend on serum immunoglobulins that require the *V*~*H*~*S107.1.42* gene.

Materials and Methods
=====================

Materials and Methods are available in the online-only Data Supplement.

Results
=======

Normal B-Cell Development in the Absence of the *V*~*H*~*S107.1.42* Gene
------------------------------------------------------------------------

The production of T15-id antibodies is thought to be critically dependent on the *V*~*H*~*S107.1.42* gene.^[@R18],[@R24],[@R29]^ However, the in vivo function of *V*~*H*~*S107.1.42* with regard to B-cell development and atherosclerosis has to date not been determined. We first quantified the expression levels of the *V*~*H*~*S107.1.42* gene compared with those of the neighboring *V*~*H*~ genes in splenic B-1 cells using previously published mRNA-seq analysis of sorted cell populations from the spleen^[@R30]^ (Figure [1](#F1){ref-type="fig"}A). When compared with the most highly expressed B-1 *V*~*H*~ gene, namely *V*~*H*~*11.2.53*, *V*~*H*~*S107.1.42* is expressed 77-fold lower (Figure 1B) and is only the 61st most highly expressed functional *V*~*H*~ gene of the 113 measured in splenic B-1 lymphocytes. Next, we crossed *V*~*H*~*S107.1.42*^−/−^ mice onto the *Apoe*^−/−^ background, so that effects of *V*~*H*~*S107.1.42* in the context of hyperlipidemia and spontaneous atherosclerotic plaque formation could be ascertained. We confirmed these mice were deficient for the VHS107.1.42 gene by designing PCR primers specific for this gene segment. Whereas we could readily detect a positive PCR band in control Apoe--/-- VHS107.1.42+/-- mice for both the VHS107.1.42 and the related VHS107.3.62 genes, we could only detect the presence of VHS107.3.62 in Apoe--/-- S107.1.42--/-- experimental mice (Figure 1C), consistent with the fact that the VHS107.1.42 has been deleted in experimental mice. Noticeably, we could also confirm the presence of the most 5′ and 3′ proximal genes to *V*~*H*~*S107.1.42*, namely *V*~*H*~*Q52.13.40* and the *V*~*H*~*S107.2pg.43* pseudogene, respectively (Figure 1C). Therefore, the *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice are deleted for the *V*~*H*~*S107.1.42* gene in a minimally intrusive manner that has not lead to spurious deletions within the neighboring immunoglobulin heavy chain environment.

![Spleen B-cell development in the absence of the VHS107.1.42 gene. **A**, Schematic representation of the immunoglobulin heavy chain with selected *V*~*H*~ genes annotated and the region around *V*~*H*~*S107.1.42* enlarged. Previously published mRNA-seq reads are indicated and displayed logarithmically as reads per million (RPM). The *V*~*H*~*S107.1.42* gene is outlined with a red box. **B**, Expression levels in RPM of *V*~*H*~*S107.1.42* and *V*~*H*~*11.2.53* genes from spleen B1 and follicular B cells. **C**, Polymerase chain reaction amplification from genomic DNA of the *V*~*H*~*S107.3.62*, *V*~*H*~*S107.1.42*, *V*~*H*~*S107.2pg.43*, and *V*~*H*~*Q52.13.40* genes from *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ control and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice as indicated. **D**, Fluorescence-activated cell sorter analysis of bone marrow for B-cell differentiation in *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/+*^, *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^, and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ mice aged 4 to 6 wk. Cells were gated to calculate absolute cell numbers for B1 (CD19^+^B220lo), B-2 (CD19^+^B220^+^), pro-B (CD19^+^B220^+^c-Kit^+^CD25^−^IgM^−^), pre-B (CD19^+^B220^+^c-Kit^−^CD25^+^IgM^−^), immature B (CD19^+^B220loIgM^+^), and recirculating (CD19^+^B220^+^IgM^+^) populations as shown in the graphs on the **right**. Each point represents an individual mouse, and error bars represent SEM.](atv-36-25-g001){#F1}

In the mouse, bone marrow lymphocytes commit to the B-cell lineage at the pro-B stage of development (defined CD19^+^c-Kit^+^) with *V*~*H*~--*DJ*~*H*~ recombination of the immunoglobulin heavy chain also occurring at this developmental stage. Successful recombination of one of the IgH alleles results in the formation of the pre--B-cell receptor at the pre--B-cell stage (CD19^+^CD25^+^IgM^−^) followed by immunoglobulin light chain recombination and progression to the immature stage. Finally, B lymphocytes exit from the bone marrow to the spleen for the final maturation stages but can return as recirculating B cells. It has previously been reported that between 32% and 64% of hybridomas obtained from aged *Apoe*^−/−^ mice on a hybrid C57BL/129 background specifically recognize OxLDL,^[@R31]^ and that some of these secrete antibodies of the T15-id.^[@R12]^ Therefore, it was possible that loss of the *V*~*H*~*S107.1.42* encoded T15-id repertoire may impact B-cell development in the context of an *Apoe*^−/−^ background even though, as described above, this *V*~*H*~ gene is not highly expressed. Therefore, we analyzed early B-cell development in *V*~*H*~*S107.1.42*-deficient mice through fluorescence-activated cell sorter analysis of the bone marrow from 4- to 6-week-old *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/+*^, *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^, and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ mice (Figure 1D). We found no significant differences in the ratios or absolute cell numbers of any B-cell examined stages in the 3 cohorts of mice. Therefore, we conclude that loss of a single or both copies of the *V*~*H*~*S107.1.42* gene does not affect early B-cell development in the bone marrow.

Role of the *V*~*H*~*S107.1.42* Gene in the Formation of Mature B-Cell Compartments and the Response to Phosphocholine-KLH Immunization
---------------------------------------------------------------------------------------------------------------------------------------

Mature B-1 cells can be readily isolated in the spleen and peritoneal cavity of the mouse. Therefore, we quantified the total number of B-1 (CD19^+^B220lo) and B-2 (CD19^+^B220^+^) cells at these 2 sites. Fluorescence-activated cell sorter analysis of the spleen from 10- to 14-week-old *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/+*^, *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^, and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ mice demonstrated consistent numbers of B-1 and B-2 lymphocytes across all 3 genotypes (Figure [2](#F2){ref-type="fig"}A), strongly arguing against a critical function of the *V*~*H*~*S107.1.42* gene in the generation of the peripheral B-1 cell population. Furthermore, these CD19^+^B220lo B-1 cells were uniformly CD43^+^ and could be further subdivide into CD5^+^ (B-1a) and CD5^−^ (B-1b) populations. We also repeated this analysis on the peritoneal cavity of 10- to 14-week-old mice (Figure 2B), and again we could not detect any significant differences in the mature B-1 and B-2 cell populations regardless of the presence or absence of the *V*~*H*~*S107.1.42*^−/−^ immunoglobulin heavy chain gene.

![The dependence of peripheral B-cell development and immune responses on the VHS107.1.42 gene. **A**, Representative fluorescence-activated cell sorter (FACS) analysis of splenic B-cell populations in *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/+*^, *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ mice and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ mice aged 10 to 14 wk shown in the **left**. Cells were gated to calculate absolute cell numbers for B-1 (CD19^+^B220lo) and B-2 (CD19^+^B220^+^) populations. Each point represents an individual mouse, and error bars represent SEM. Spleen B-1 and B-2 cells from 6-wk-old mice were further analyzed for CD5 and CD43 expression as shown in the histograms. **B**, FACS analysis of the peritoneal cavity from 10- to 14-wk-old mice as described in **A**. **C**, Spleen analysis from *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ control and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice aged 10 to 12 wk injected with phosphocholine (PC)-KLH/alum and analyzed after 6 d. **Top**, Germinal center B cells (CD19^+^B220^+^IgD-CD95^+^GL7^+^) and the (**bottom**) plasma cells (CD19loB220loCD138^+^CD28^+^). Absolute cell numbers for the germinal center (GC) and PC cell populations calculated from these gates are depicted in the graphs in the **right**. Control mice are depicted by white bars and experimental in gray. **D**, ELISA measurements of plasma antiphosphocholine IgM responses in plasma 6 d after PC-KLH/alum immunization from *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ control and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice. **E**, Competition ELISA with pooled plasma from *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ mice captured with AB1.2 (anti-T15-id) and competed as indicated.](atv-36-25-g002){#F2}

It has been previously reported that *V*~*H*~*S107.1.42*^−/−^ mice have strongly reduced primary immune responses to the hapten phosphocholine. We repeated this analysis using control *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice immunized with phosphocholine-KLH (phosphocholine coupled to keyhole limpet hemocyanin) with Alum adjuvant. Both control and experimental mice robustly formed germinal centers and produced plasma cells 6 days after primary immunization (Figure 2C). However, we observed a significant 88% reduction in IgM antibodies recognizing phosphocholine in experimental mice consistent with the original description of the *V*~*H*~*S107.1.42*^−/−^ mouse strain (Figure 2D). Finally, we performed competition ELISA assays on control mice using the AB1-2 clone that recognizes the T15-id as a capture antibody and competed with BSA, phosphocholine-BSA, and AB1-2 (Figure 2E). Addition of phosphocholine-BSA and AB1-2, but not BSA, efficiently competed binding indicating that this primary antiphosphocholine response consists of the T15-id. Taken together, control *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice have indistinguishable B-cell compartments under steady state conditions; however, the *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ strain manifests a highly specific defect in the primary immune response to the phosphocholine hapten.

Contribution of the *V*~*H*~*S107.1.42* Encoded Antibodies to Humoral Immune Responses Against Common Atherosclerosis Antigens
------------------------------------------------------------------------------------------------------------------------------

We next wished to determine how the loss of the *V*~*H*~*S107.1.42* gene segment would affect the titers of selected immunoglobulins by using ELISA assays on plasma from male (Figure [3](#F3){ref-type="fig"}A) and female (Figure 3B) mice aged 10 or 20 weeks. Total plasma IgM levels in control *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice were similar. Surprisingly, however, reactivity of plasma IgM with the AB1-2 monoclonal antibody, which specifically recognizes the heavy and light chain of T15-id,^[@R32]^ was unaffected by the loss of the *V*~*H*~*S107.1.42* gene. Multiple antibody specificities, including the *V*~*H*~*S107.1.42* encoded T15-id, react against phosphocholine (phosphocholine) and to antigens present in Cu^2+^ OxLDL. We next measured plasma IgM antibodies reacting against these antigens as well as another model of OxLDL, malondialdehyde modified LDL (MDA-LDL). Similar levels of reactivity against phosphocholine, Cu^2+^ OxLDL, and malondialdehyde modified LDL were present in both control *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice. We next repeated these experiments using *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^*+/+*^ and *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^−/−^ mice and again found similar responses to these antigens (Figure 3C). In summary, the loss of the *V*~*H*~*S107.1.42*^−/−^ gene does not reduce the plasma IgM titers against common atherosclerosis-associated antigens.

![The loss of the VHS107.1.42 gene and humoral immune responses in atherosclerosis. ELISA analysis of 10- and 20-wk-old (**A**) male and (**B**) female *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ control and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice. Indicated are the total plasma IgM levels, titers of plasma IgM recognized by the AB1-2 antibody normalized to total IgM levels and plasma IgM levels against the common atherosclerosis-associated antigens phosphocholine (PC)-BSA, Cu^2+^ oxidized low-density lipoprotein (CuOx-LDL) and malondialdehyde modified (MDA)-LDL all normalized to total plasma IgM levels. Each point represents an individual mouse, and error bars represent SEM. Control mice are depicted by white bars, and experimental are by gray. **C**, Analysis of male *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^*+/+*^ control and *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice.](atv-36-25-g003){#F3}

Normal Development of Atherosclerosis in the Absence of *V*~*H*~*S107.1.42* Encoded Immunoglobulins
---------------------------------------------------------------------------------------------------

To gain insight into the role of the *V*~*H*~*S107.1.42* gene in atherosclerosis development, we examined the extent of atherosclerotic lesion formation in our cohort of control *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ mice. We measured plaque development by en face staining of aortas in male and female mice at 10 and 20 weeks fed a normal chow diet. We found no significant difference in lesion formation between control and experimental mice at either 10 (Figure [4](#F4){ref-type="fig"}A) or 20 (Figure 4B) weeks regardless of sex. To evaluate whether *V*~*H*~*S107.1.42* could help protect against atherosclerosis in the context of a Western diet, 10-week-old control male *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice were placed on a Western diet for 10 to 12 weeks. Analysis of the aortas by en face staining again revealed no significant difference in atherosclerosis plaque formation (Figure 4C). Finally, we determined atherosclerotic plaque formation in a separate strain of atherosclerotic prone mice. It has previously been shown that *Ldlr*^−/−^ mice develop atherosclerosis in a diet-dependent manner.^[@R33]^ Therefore, we analyzed *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^*+/+*^and *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^−/−^ mice to determine whether the *V*~*H*~*S107.1.42* gene protects against atherosclerosis in a strain-dependent manner. Male mice aged 12 weeks were placed on a Western diet for a further 8 weeks before analysis. Similar to the *Apoe*^−/−^ strain, induction of atherosclerosis in *Ldlr*^−/−^ mice through Western diet was not affected by the loss of the *V*~*H*~*S107.1.42* gene (Figure 4D). In summary, mice deficient for *V*~*H*~*S107.1.42* develop atherosclerotic plaques similar to control mice independently of age, sex, diet, or genetic background.

![The role of the VHS107.1.42 gene in the initiation and maintenance of aortic atherosclerosis plaque formation. **A**, Sudan IV en face staining of control *Apoe*^−/−^ *V*~*H*~*S107.1.42*^+/−^ and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^experimental mice at 10 wk fed on conventional chow diet. Quantification of the total percentage lesion area in the aorta for male and female mice at 10 wk are shown with a representative picture from female mice depicted in the **right**. Each data point represents an individual mouse, and error bars indicate SEM. **B**, As above, but with mice at 20 wk on conventional chow diet. **C**, Atherosclerosis in male *Apoe*^−/−^ *V*~*H*~*S107.1.42*^+/−^ control and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice fed a Western diet for 10 to 12 wk. **D**, Aortic lesion development in male *Ldlr*^−/−^ VHS107.1.42^+/+^ control and *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice fed a Western diet for 8 wk.](atv-36-25-g004){#F4}

Function of *V*~*H*~*S107.1.42* Antibodies on Plasma Lipids
-----------------------------------------------------------

T15-id antibodies have been shown to form circulating immune complexes with ApoB100-carrying particles and have been suggested to function in preventing the uptake of OxLDL by macrophages.^[@R13],[@R34]^ Therefore, we determined the plasma concentrations of cholesterol and triglycerides in control *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice at 20 weeks on both a normal and a Western diet, as well as *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^*+/+*^ and *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^−/−^ mice maintained on a Western diet. Although plasma cholesterol levels were not altered in control *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice on either normal or Western diet, we did observe a significant decrease (26%) in plasma cholesterol levels in experimental *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^−/−^ versus *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^*+/+*^control mice (Figure [5](#F5){ref-type="fig"}A). This pattern was repeated when plasma triglycerides were measured, with no effect seen on loss of the *V*~*H*~*S107.1.42* gene on the *Apoe*^−/−^ background, but a significant 47% drop in experimental *Ldlr*^−/−^ *V*~*H*~*S107.1.42* ^−/−^ versus *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^*+/+*^ control mice (Figure 5B). We next determined the relative association of cholesterol with different lipoproteins by plasma high-performance liquid chromatography fractionation. Analysis of pooled serum revealed a small increase in cholesterol associated with high-density lipoprotein in experimental *Ldlr*^−/−^ *V*~*H*~*S107.1.42* ^−/−^ versus *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^*+/+*^control mice (Figure 5C). Interestingly, loss of the *V*~*H*~*S107.1.42* gene correlated with small but significant decreases in body weight on both the *Apoe*^−/−^ and *Ldlr*^−/−^ genetic backgrounds (Figure 5D). These experiments would indicate that any humoral immune-mediated effects on lowering blood cholesterol and triglyceride levels are likely to be independent of the *V*~*H*~*S107.1.42* T15-id antibody specificity.

![Body weight and plasma lipid levels in the absence of the VHS107.1.42 gene. **A**, Plasma from 20-wk-old male *Apoe*^−/−^ *V*~*H*~*S107.1.42*^+/−^ control and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^experimental mice (**left** and **middle**) or *Ldlr*^−/−^ VHS107.1.42^+/+^ control and *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice (**right**) were assayed to quantify total blood cholesterol levels. *Apoe*^−/−^ mice were either maintained on a conventional diet throughout or were first placed on conventional diet until 10 wk followed by 10 to 12 wk on Western diet. The *Ldlr*^−/−^ strain was placed on a conventional diet for 12 wk followed by 8 wk on a Western diet. Each point represents an individual mouse, and error bars show SEM. Control mice are depicted by white bars, and experimental are by gray. \**P*\<0.05 vs control. **B**, Plasma triglycerides levels from mice cohorts as described above. \*\**P*\<0.01 vs control. **C**, High-performance liquid chromatography fractionation of plasma lipoproteins to determine relative cholesterol content from *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^+/+^ control and *Ldlr*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice. **D**, Body weight from mice maintained on a Western diet as described above. \*\*\*\**P*\<0.0001 vs control. CR indicates chylomicron remnant; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NC, normal chow; and VLDL, very low-density lipoprotein.](atv-36-25-g005){#F5}

Atherosclerotic Plaque Formation in the Aortic Root Is Independent of *V*~*H*~*S107.1.42*
-----------------------------------------------------------------------------------------

Atherosclerotic plaque formation in the aortic root is associated with deposition of IgM that has previously been shown to contain the T15-id. Therefore, we quantify the extent of plaque formation in the absence of the *V*~*H*~*S107.1.42* encoded T15-id. Serial aortic root sections from female control *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice aged 20 weeks maintained on normal chow diet were stained with Oil Red O, and the total lesion area was quantified. We did not detect any significant differences in plaque formation between control and experimental mice similar to the results from the en face analysis of the aorta. Female *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/+*^ had a similar extent of atherosclerosis development in the aortic root as *Apoe*^−/−^ *V*~*H*~*S107.1.42*^*+/*−^ and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ mice, indicating that that plaque formation proceeds similarly regardless of the status of the *V*~*H*~*S107.1.42* gene (Figure [6](#F6){ref-type="fig"}A). In addition, subjecting male mice to 8 weeks of Western diet approximately doubled the extent of atherosclerosis but again quantification revealed no difference between control and experimental mice (Figure 6B). Finally, using immunofluorescence, we were also able to robustly observe widespread IgM deposition in the atherosclerotic plaque of 20-week-old female mice maintained on a normal chow diet even in the absence of the *V*~*H*~*S107.1.42* gene encoded T15-id antibodies (Figure 6C).

![Aortic root atherosclerosis and IgM deposition in VHS107.1.42-deficient mice. **A**, Oil-red-O--stained aortic roots of 20-wk female *Apoe*^−/−^ *V*~*H*~*S107.1.42*^+/+^, *Apoe*^−/−^ *V*~*H*~*S107.1.42*^+/−^, and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ mice maintained on a conventional chow diet. Quantification of the mice is shown on the **right**. The areas under the curves did not differ significantly between experimental and control groups. **B**, Male *Apoe*^−/−^ *V*~*H*~*S107.1.42*^+/−^ and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ mice fed conventional diet (**top**) or a Western diet for 8 wk (**bottom**). **C**, Confocal microscopy of total IgM (green) staining in aortic root sections from 20-wk-old female *Apoe*^−/−^ *V*~*H*~*S107.1.42*^+/−^ control and *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice on normal chow (DAPI stained in blue). NC indicates normal chow.](atv-36-25-g006){#F6}

Discussion
==========

Our current understanding of the pathology of both atherosclerotic plaque formation and protection from *S pneumoniae* infection strongly implicates a protective function for T15-id natural antibodies secreted by the B-1 subset of mature B cells. In this study, we have crossed mice that are deleted for the *V*~*H*~*S107.1.42* gene, which was thought to be required to produce the T15-id, with well-characterized atherosclerosis-prone mouse strains to determine the in vivo function of this humoral entity on plaque formation. In contrast to the protection from lethal infection from *S pneumoniae* that the *V*~*H*~*S107.1.42* confers, the development of atherosclerosis seems to be unaffected by the loss of the *V*~*H*~*S107.1.42* gene.

The 2 major V~H~ genes expressed in mature B-1 cells are the *V*~*H*~*11.2.53* and *V*~*H*~*12.1.78* segments.^[@R30]^ Interestingly, these genes when combined with the correct κ light chain are known to bind phosphatidylcholine, but their function in atherosclerosis has not been determined. In contrast, *V*~*H*~*S107.1.42* is only expressed in a minor fraction of B-1 cells, and unsurprisingly deletion of *V*~*H*~*S107.1.42* did not elicit a detectable defect in B-1 lymphopoiesis.

We were unable to observe any differences in the humoral responses to common atherosclerosis antigens after crossing *V*~*H*~*S107.1.42*^−/−^ mice with either the *Apoe*^−/−^ or the *Ldlr*^−/−^ strains. This is in agreement with previous experiments that revealed normal titers of antibodies against modified LDL in the *V*~*H*~*S107.1.42*^−/−^ strain when compared with control mice.^[@R35]^ Furthermore, loss of *V*~*H*~*S107.1.42*^[@R24]^ still permitted humoral responses to phosphocholine in otherwise nonhyperlipidemic mice. However, we did not observe the expected decrease in T15-id reactivity in our hyperlipidemic strains. Although *V*~*H*~*S107.1.42* is thought to be an essential component of the T15-id, many studies have shown that alternative immunoglobulin heavy chains can participate in a T15-id^+^ positive V(D)J rearrangement. Notably this seems to be strain specific. In the BALB/c strain, \>99% of the T15-id incorporates *V*~*H*~*S107.1.42*, whereas in BALB/c×CBA F1 hybrids, this ratio drops to 32%.^[@R32]^ Interestingly, the majority of peritoneal B-1a cells from the BALB/c strain that react against both phosphocholine and AB1-2 seem to use a *V*~*H*~*11* immunoglobulin heavy chain gene.^[@R28]^ Crucially, however, it is the canonical T15-id incorporating *V*~*H*~*S107.1.42* that provides a protective immune response against *S pneumoniae*. In this regard, it is noticeable that the BALB/c strain is the most resistant to lethal *S pneumoniae* infection,^[@R36]^ and it could be speculated that its almost total incorporation of *V*~*H*~*S107.1.42* in its T15-id may confer this serological protection. The BALB/c strain is also among the most resistant to diet-induced atherosclerosis,^[@R37]^ and the relative contribution of *V*~*H*~ genes to its atheroprotective humoral immune repertoire, not least within the T15-id, may in part contribute to atherosclerosis resistance. Noticeably, the *Apoe*^−/−^ *V*~*H*~*S107.1.42*^−/−^ experimental mice used in this study still had a strongly impaired acute response to phosphocholine, as measured by antiphosphocholine IgM titers in the primary immune response to phosphocholine-KLH immunization. This is consistent with the original description of *V*~*H*~*S107.1.42*^−/−^ mice, which also showed a highly impaired primary immune response, whereas secondary immune responses were less affected because of the production of heteroclitic antibodies.^[@R24]^ Similarly, we demonstrate that in aged mice, the antibody titers against phosphocholine remained constant in the absence of *V*~*H*~*S107.1.42*. Therefore, we conclude that the acute *V*~*H*~*S107.1.42*-dependent antiphosphocholine IgM primary immune response, which is critical against *S pneumoniae* infection, is dispensable for the protection against atherosclerosis. Alternatively, hypercholesterolemia in atherosclerosis-prone mice fails to robustly trigger this primary response in marked contrast to the vigorous reaction after immunization or bacterial infection. This suggests that hypercholesterolemia affects T15-id IgM responses differently or to a lesser extent. However, this may not be the case for other T15-id responses, produced independently of *V*~*H*~*S107.1.42*. In line with a protective role of T15-id IgM responses on immunization, expansion of T15-id IgM by pneumococcal immunization has been shown to decrease atherosclerotic lesion formation.^[@R38]^

In addition, multiple antigenic epitopes on OxLDL are important in the immune response to atherosclerosis and likely these function in a redundant manner or elicit a large number of minor responses that are not easily distinguished. Notably, we observed normal deposition of IgM within aortic root plaques even in the absence of *V*~*H*~ *S107.1.42*-containing T15-id antibodies.

In summary, we have used 2 different mouse strains that are susceptible to atherosclerosis and rendered these strains unable to produce *V*~*H*~*S107.1.42*-containing antibodies. Under all the conditions we tested, we were unable to detect an effect on atherosclerosis, regardless of sex, diet, age, or anatomic location of the plaque. Therefore, we conclude that the *V*~*H*~*S107.1.42* gene is dispensable for atherosclerosis initiation and maintenance, which is in strong contrast to the protection against *S pneumoniae* that this immunoglobulin heavy chain gene segment confers. We further speculate that protection against atherosclerosis mediated by IgM is likely to be mediated by many different *V*~*H*~ genes with multiple specificities, for example, for epitopes of OxLDL.
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Significance
============

It is thought that humoral immune responses in the form of natural IgM protects against atherosclerosis. T15 idiotype antibodies have been implicated in the recognition and clearing of oxidized low-density lipoprotein and being essential for protection from *Streptococcus pneumoniae* infection. Therefore, it has been hypothesized that there is a common genetic determinant in the protection against both atherosclerosis and *S pneumoniae* infection. We have crossed mice deficient for the *V*~*H*~*S107.1.24* gene with both the *Apoe*^−/−^ and *Ldlr*^−/−^ strains. We find no evidence that *V*~*H*~*S107.1.24* protects against atherosclerosis or is critical to maintaining normal plasma titers of antibodies against antigens implicated in atherosclerosis. Our results indicate that antibody-mediated protection against atherosclerosis by B lymphocytes is likely to require multiple immunoglobulin heavy chain genes.
